Encouragingly, this anti-tumor effect converted into a pro-
survival effect also, as the authors noted an improvement in the
median survival of mice treated with the long - term
expanded iPSC - NKs or PB - NKs from 73 days to 98 and 97 days, respectively (See adjoined figure).